Acquisitions20 Feb 2026, 05:12 pm
Jasub Property Holdings LLP Acquires 6.59% Stake in Cohance Lifesciences Ltd via Open Market Transactions
AI Summary
Jasub Property Holdings LLP, along with its Persons Acting in Concert (PAC), has acquired a 6.59% stake in Cohance Lifesciences Ltd (formerly Suven Pharmaceuticals Limited) through open market transactions. The acquisition was made between September 8, 2025, and January 8, 2026. Jasub Property Holdings LLP acquired 7,000,000 shares, while its PACs—Jasti Property and Equity Holdings Private Limited, Mrs. Venkata Subbamma Jasti, Mr. Venkateswarlu Jasti, and Mrs. Sudharani Jasti—acquired an additional 1,73,16,009 shares. This acquisition increased Jasub Property Holdings LLP's stake in Cohance Lifesciences Ltd from 0% to 6.59% and the total diluted share/voting capital of the TC to 39,22,07,995 shares.
Key Highlights
- Jasub Property Holdings LLP acquired a 6.59% stake in Cohance Lifesciences Ltd through open market transactions.
- The acquisition took place between September 8, 2025, and January 8, 2026.
- Jasub Property Holdings LLP acquired 7,000,000 shares, and its PACs acquired an additional 1,73,16,009 shares.
- This acquisition increased Jasub Property Holdings LLP's stake in Cohance Lifesciences Ltd from 0% to 6.59%.
- The total diluted share/voting capital of the TC increased to 39,22,07,995 shares.